Serum uric acid is a strong predictor of stroke in patients with non- insulin-dependent diabetes mellitus

Stroke

Volumn 29, Issue 3, 1998, Pages 635-639

  Lehto, Seppo ^d   Niskanen, Leo ^d   Rönnemaa, Tapani ^a,b   Laakso, Markku ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d NONE

Author keywords

Diabetes mellitus; Mortality; Stroke onset; Uric acid

Indexed keywords

URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; STROKE; URIC ACID BLOOD LEVEL;

EID: 0031942817     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.3.635     Document Type: Article

References (50)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987;3:463-524.
2. Barrett-Connor E, Khaw K-T. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
3. Wolff PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
4. Bierman EL. Atherosclerosis in diabetes. Arterioscler Thromb. 1992;12: 647-656.
5. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996; 27:63-68.
6. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid: a facet of hyperinsulinemia. Diabetologia. 1987;30:713-718.
7. Facchini F, Chen YDI, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266: 3008-3011.
8. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WB. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol. 1985;121:11-18.
9. Bengtsson C, Lapidus L, Stendahl C, Waldenström J. Hyperuricaemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1988;224:549-555.
10. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. Clin Epidemiol. 1989;42:257-267.
11. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonano G, Bonati PA, Bergonzani M, Gnudi L, Passeri M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
12. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988;11:449-463.
13. Madsbad S, Alberti KG, Binder C, Burrin JM, Faber OK, Krarup T, Regeur L. Role of residual insulin secretion in protecting against keto-acidosis in insulin-dependent diabetes. BMJ. 1979;2:1257-1259.
14. World Health Organization. WHO Study Group on Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1985. World Health Organ Tech Rep Ser, No. 727.
15. World Health Organization. Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva, Switzerland: World Health Organization; 1983. Publication WHO/MNC/82.1, rev 1.
16. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981;12(suppl I):I-13-I-44.
17. Faber OK, Binder C. C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes. 1977;26:605-610.
18. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975;11:541-548.
19. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem. 1981;19:838-839.
20. Kostner G. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem. 1976; 22:695. Letter.
21. Fossati P, Prencipe L, Bari G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980;26: 227-231.
22. US Department of Health and Human Services. International Classification of Diseases, 9th Rev, Clinical Modification. Vol 1. Washington, DC: US Government Printing Office; 1981.
23. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-201.
24. Persky VW, Dyer AR, Idris-Soven E, Stamler J, Shekelle RB, Schoenberger JA, Berkson DM, Lindberg HA. Uric acid: a risk factor for coronary heart disease? Circulation. 1979;59:969-977.
25. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41:237-242.
26. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1995;141:637-644.
27. Rathmann W, Hauner H, Dannehl K, Gries FA. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabet Med. 1993;19:159-166.
28. Bansal BC, Gupta RR, Bansal MR, Prakash C. Serum lipids and uric acid relationship in ischemic thrombotic cerebrovascular disease. Stroke. 1975; 6:304-307.
29. Crouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR, McMahan MR, Harpold GH. Risk factors for extracranial carotid artery atherosclerosis. Stroke. 1987;18:990-996.
30. Vigna GB, Bolzan M, Romagnoni F, Valerio G, Vitale E, Zuliani G, Fellin R. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation. 1992;85:2205-2211.
31. Schneidau A, Harrison M, Hurst C, Wilkes HC, Meade TW. Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery. Stroke. 1989;20:1466-1471.
32. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study. Am J Epidemiol. 1995;142:288-294.
33. Selby JV, Friedman GD, Quesenberry CPJ. Precursors of essential hyper-tension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol. 1990;131:1017-1027.
34. Wilson PWF, Garrison RJ, Abbott RD, Castelli WB. Factors associated with lipoprotein cholesterol levels: the Framingham Study. Arteriosclerosis. 1983;3:273-281.
35. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, Reaven GM. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. Int J Med. 1993;234:25-30.
36. Ferris TF, Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med. 1993;1968:359-365.
37. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93:817-821.
38. Kobrin I, Frohlich ED, Ventura HO, Messerli FH. Renal involvement follows cardiac enlargement in essential hypertension. Arch Intern Med. 1986;146:272-276.
39. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA. 1993;270:354-359.
40. DeFronzo RA, Ferranini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic vascular disease. Diabetes Care. 1991;14:173-194.
41. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys. 1994;310:352-359.
42. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent. J Clin Invest. 1994;94:1172-1179.
43. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14:615-631.
44. Töyry JP, Niskanen LK, Länsimies EA, Partanen KP, Uusitupa MIJ. Autonomie neuropathy predicts the development of stroke in patients with non-insuhn-dependent diabetes mellitus. Stroke. 1996;27:1316-1318.
45. Baynes JW. Role of oxidative stress in the development of complications in diabetes mellitus. Diabetes. 1991;40:405-412.
46. Suama C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Tromb Vasc Biol. 1995;15:1616-1624.
47. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:310-318.
48. Feingold KR, Grunfeld C. Role of cytokines in including hyperlipidemia. Diabetes. 1992;41(suppl 2):97-101.
49. Visy J, Le-Coz P, Chadefaux B, Fressinaud C, Woimant F, Marquet J, Zittoun J, Visy J, Vallat JM, Haquenau M. Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology. 1991;41:1313-1315.
50. Kuwano K, Ikeda H, Oda T, Nakayama H, Koga Y, Toshima H, Imaizumi T. Xanthine oxidase mediates cyclic flow variations in a canine model of coronary arterial thrombosis. Am J Physiol. 1996;270:1993-1999.